Summary: The results of transcatheter renal artery embolization are presented in a small group of patients with end-stage renal disease. Five of the patients were suffering from severe drug-resistant hypertension, one from rejection of a renal transplant and one had heavy haematuria from a transplant kidney. All seven patients benefited from the procedure with no significant morbidity. The procedure of renal artery embolization and its potential complications are discussed. It is concluded that renal ablation by transcatheter embolization is not only effective, but also has a significantly lower morbidity and mortality than surgical nephrectomy in this group of patients with end-stage renal disease and associated problems.
Introduction
Prior to the advent of arterial embolization, patients with renal failure and severe hypertension were sometimes treated by bilateral nephrectomy in an attempt to lower their blood pressure. This Figure 1) . A low osmolar non-ionic contrast medium, Iohexol 300, was used throughout. The vessels to the kidney were then selectively catheterized using either a femoral-visceral (Cobra) or a femoral-cerebral (Sidewinder) catheter with only a single end hole ( Figure 2 ).
To eliminate renin secretion by the juxtaglomerular apparatus of native kidneys, a combination of embolization materials was used to occlude small vessels in an attempt to prevent formation ofcollateral vessels which could result in the recurrence of hypertension. Absorbable gelatin sponge (Sterispon), a temporary embolic agent, and lyophilized dura mater, a 'permanent' agent, were used to embolize small vessels. These agents were suspended in contrast 
